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Gliomas, primary brain cancers, are characterized by remarkable invasiveness and fast
growth. While they share many qualities with other solid tumors, gliomas have developed
special mechanisms to convert the cramped brain space and other limitations afforded
by the privileged central nervous system into pathophysiological advantages. In this
review we discuss gliomas and other primary brain cancers in the context of acid-base
regulation and interstitial acidification; namely, how the altered proton (H+) content
surrounding these brain tumors influences tumor development in both autocrine and
paracrine manners. As proton movement is directly coupled to movement of other ions,
pH serves as both a regulator of cell activity as well as an indirect readout of other cellular
functions. In the case of brain tumors, these processes result in pathophysiology unique to
the central nervous system. We will highlight what is known about pH-sensitive processes
in brain tumors in addition to gleaning insight from other solid tumors.
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Primary brain tumors stand out amongst solid tumors in both
their location and their pathophysiology. The most common and
aggressive type of primary brain tumors, glioma, invades brain
space while simultaneously destroying surrounding tissue in an
attempt to increase brain real estate (Watkins and Sontheimer,
2012). As with other solid tumors, gliomas display enhanced
glycolysis and heightened acidification of the tissue interstitium
(Vlashi et al., 2011). Unlike other solid tumors, however, gliomas
face both brain-specific cellular interactions (Charles et al., 2011)
and chemical composition (Irani, 2008). This results in unique
pathophysiological consequences. In this review, we will high-
light the mechanisms by which brain tumors regulate both their
intracellular pH (pHi) and also the pH of the surrounding tissue
(pHe), and how this pH regulation affects tumor pathogenicity.
pHi REGULATION
Tumor cells constantly struggle to resist the electrochemical gra-
dients of protons, weak acids, and weak bases generally acidifying
the cell (Webb et al., 2011; Bevensee and Boron, 2013). Thus a
major driving force in understanding tumor acid-base physiol-
ogy is understanding the transport of protons across the plasma
membrane. This transport uses either energy substrates or is
coupled to the electrochemically-favorable transport of a sec-
ond molecule. The following section explains the roles of various
H+-coupled transporters and exchangers in brain tumor pHi
regulation (Figure 1).
Most initial studies on glioma cell pHi regulation used C6
rat glioma cells, which were generated by exposure to N, N ′-
nitroso-methylurea and used throughout the 1980s and 1990s as
a convenient cell line for studying astrocytic physiology including
cytotoxic edema, cerebral ischemia, and volume regulation under
osmotic challenge. For a thorough review of the C6 line, please
refer to Grobben et al. (2002). These studies often used changes
in pHi as a proxy for transport of other ions such as Na+, K+,
and Cl−. Only recently did the focus of inquiry shift to human
glioma. With this caveat in mind, we will review some older lit-
erature that describes pH regulatory systems in C6 followed by
newer literature on the biological targets of pH changes in human
gliomas.
Na+/H+ EXCHANGE
Na+/H+ exchange (NHE) was originally identified in mouse
muscle fibers (Aickin and Thomas, 1977) where it was shown
to be the major regulator of pHi. Owing to a strong inwardly-
directed electrochemical gradient for Na+, it is ideally suited for
proton extrusion, thereby alkalinizing pHi while simultaneously
acidifying the interstitium (Figure 1). The first implications of
NHE in glioma cells came from studies in C6 rat glioma cells and
neuroblastoma x glioma hybrid cells (NG108-15), both used as
model systems investigating NHE in adrenergic signaling (Hertel
and Staehelin, 1983; Isom et al., 1987a; Nunnari et al., 1987). Later
studies involved NHE in a wide variety of signaling pathways
(Isom et al., 1987b; Neve et al., 1992). C6 glioma cells were also
considered a viable model of glial cells during acidosis and postis-
chemic brain edema, where pHi served as a secondary readout
for NHE involvement in osmotic swelling and regulatory volume
increase (Jakubovicz et al., 1987; Kempski et al., 1988; Jakubovicz
and Klip, 1989; Staub et al., 1994) under mildly acidotic condi-
tions (pHe 6.0–7.0). Later, it was postulated that NHE served to
maintain homeostatic pHi at the cost of cell swelling (Kempski
et al., 1990; Staub et al., 1990). This exchange was temperature-
dependent, with increased activity at higher temperatures (Lui
et al., 1995; Mountian et al., 1996). While these studies sought to
implicate glial cells in cytotoxic edema, they also hinted at a robust
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FIGURE 1 | Major components of pHi regulation in glioma cells. Unlike
astrocytes, glioma cells rely heavily on HCO−3 -independent mechanisms to
regulate their pHi. The predominant acid extruder is NHE1, a Na+/H+
exchanger. All of these components except for the H+ V-ATPase also
contribute to C6 glioma osmotic regulation from the transport of the
counter-ion.
NHE mechanism that would soon be implicated as a hallmark of
brain tumors.
The initial reports of NHE in brain tumor cell activity came
from C6 glioma spheroids, where H+ production under high
glucose conditions was diminished by amiloride (Acker et al.,
1992). Subsequently, Shrode et al. characterized differences in
pHi regulation between C6 glioma cells and astrocytes, with the
largest being a lack of Na+/HCO−3 transport in glioma cells
(Shrode and Putnam, 1994). McLean et al. were the first to look
at various human glioma cell lines and noted a significant ele-
vation in Na+/H+ exchanger subtype 1 (NHE1) expression, an
increase in baseline pHi, and an increased reliance on HCO
−
3 -
independent pathways versus primary rat astrocytes (McLean
et al., 2000). As the NHE1 blocker amiloride is nonspecific and
has off-target effects on glioma cells (Hegde et al., 2004), spe-
cific blockade of NHE1 with HOE642 (cariporide) confirmed a
tonic activity for the NHE1 exchanger in glioma cell pHi regula-
tion (Glunde et al., 2002). Interestingly, DNA hypermethylation
decreases NHE1 expression in oligodendroglioma versus higher-
grade gliomas, potentially limiting the growth potential of these
lower-grade gliomas (Blough et al., 2012). However, there have
not been comprehensive studies of NHE subtypes in gliomas,
with one study finding absence of NHE2 and NHE3 expression
in C6 glioma cells (Willoughby et al., 2005). More recent studies
have hinted at changes in Na+/H+ exchanger recruitment to the
cell surface (Kislin et al., 2009) and spatial organization within the
tumor (Grillon et al., 2011).
Cl−/HCO−3 EXCHANGE
C6 glioma cells express both Na+-dependent and Na+-
independent modes of Cl−/HCO−3 exchange (Figure 1). The
Na+-dependent transport is alkalinizing, while the Na+-
independent transport is acidifying in response to an intracellular
alkalinization (Shrode and Putnam, 1994); these are blocked
by the inhibitors 4,4′-diisothiocyano-2,2′-stilbenedisulfonic acid
(DIDS) and 4-acetamido-4-isothiocyanatostilbene-2,2-disulfonic
acid (SITS) (Kempski et al., 1988; Shrode and Putnam, 1994;
Mountian et al., 1996; McLean et al., 2000). Cl−/HCO−3
antiporter activity helps import Cl− ions in tandem with Na+
ions from the NHE to serve as osmotic agents for cell swelling
in the face of acidosis (Staub et al., 1990; Mountian et al., 1996).
The extrusion of HCO−3 seems to additionally act as a buffer for
lactic acid (Staub et al., 1990), a finding discovered while inves-
tigating cerebral ischemia but that extrapolates well to the tumor
microenvironment. Unlike non-transformed astrocytes, however,
it appears glioma cells strongly lean on CO2/HCO
−
3 -independent
mechanisms of acid extrusion (McLean et al., 2000).
H+-LACTATE COTRANSPORT
Proton-coupled lactate transporters help rid the cell of both
acid and lactate loads simultaneously and thus play vital roles
in tumor cellular metabolism and osmoregulation (Figure 1).
Lactate efflux was first reported in C6 glioma cells to be a pH-
dependent phenomenon, with increased efflux at alkaline pHe
(Lust et al., 1975). This transport was reversed in an astrocytoma
cell line when the extracellular lactate and proton concentrations
were increased (Lomneth et al., 1990; Tomsig et al., 1991), and
lactate uptake in glioma cells was saturable at lower concentra-
tions of lactate, indicating a carrier-dependent process (Dringen
et al., 1995). This transport can be inhibited by the lactate trans-
port inhibitors quercetin and alpha-cyano-4-hydroxycinnamate
(CHC), which when used on C6 glioma cells prevented H+-
lactate efflux and decreased pHi (Volk et al., 1997). More recently,
identification of two specific lactate transporters, MCT1 (Froberg
et al., 2001; Mac and Nalecz, 2003; Grillon et al., 2011; Miranda-
Goncalves et al., 2013) and MCT4 (Grillon et al., 2011; Miranda-
Goncalves et al., 2013) in various types of brain tumors has pro-
vided molecular targets for disrupting brain tumor metabolism
and pHi regulation.
VACUOLAR-TYPE H+-ATPase
Despite predominantly functioning as organellar proton pumps,
there is evidence that V-ATPases translocate to the plasma mem-
brane and regulate pHi in brain tumors (Figure 1). V-ATPase
inhibitors such as bafilomycin A1 depolarized the membranes
of NG108-15 neuroblastoma × glioma hybrid cells (Gerard
et al., 1994, 1998) and C6 glioma cells (Philippe et al., 2002).
Additionally, this V-ATPase was tonically active and alkalinized
C6 glioma cells at physiological pHi (Volk et al., 1998). It should
be noted, however, that plasma membrane expression of this
proton pump is not limited to gliomas but also occurs in non-
transformed astrocytes (Philippe et al., 2002). A more recent
study has isolated the a4 isoform of the V0 subunit in human
glioma samples, a subunit usually absent in normal human brain
that is expressed in the kidney and epididymis (Gleize et al.,
2012).
AQUAPORINS AND CARBONIC ANHYDRASES
Both of these protein types serve to facilitate a more rapid reg-
ulation of pHi. Carbonic anhydrases do so by catalyzing the
reversible interconversion of CO2 + H2O and HCO
−
3 + H
+, while
aquaporins may be involved in the direct flux of CO2 through
the plasma membrane (Endeward et al., 2006; Hub and De
Groot, 2006). Gliomas predominantly express carbonic anhydrase
9 (CAIX) and aquaporins 1 and 4 (AQP1 and AQP4). Aquaporins
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have also been shown to play roles in glioma cell adhesion and
maintenance of iso-osmolarity during volume regulation via H2O
flux (McCoy and Sontheimer, 2007). The direct role of these pro-
teins in brain tumor pathophysiology is outside the scope of this
review.
CONSEQUENCES OF pHi REGULATION
The most direct (and obvious) consequence of pHi regulation is
pHe alteration. The aforementioned mechanisms of pHi regula-
tion mostly act as intracellular alkalinizing agents, leading to a
large proton efflux into the extracellular space (ECS). The mag-
nitude of pHi and pHe changes depends on buffering capacity,
total compartment volume, and molecular diffusivity (Chesler,
2003). These protons do not dissipate readily in the poorly per-
fused spaces within solid tumors, resulting in pHe heterogeneity
and pockets of increased acidity. Therefore, protons may serve as
messenger molecules that alter both intratumoral and extratu-
moral physiology (Figure 2). This section will both review known
mechanisms of pH-directed pathophysiology in brain tumors as
well as draw lessons from other solid tumor types.
ION CHANNEL SIGNALING
Brain tumors possess several pH-sensitive ion channels, including
acid-sensing ion channels (ASICs), transient receptor potential
channels (TRPs), two-pore potassium channels (K2Ps), puriner-
gic receptors (P2XRs), and proton-sensing G-protein coupled
receptors (GPCRs). Here we will briefly touch upon channel
expression, subtype, and pH-sensitivity as discussed in brain
tumor literature. For a broader view of pH-sensitive ion channels
and cancer, see Glitsch (2011); for a more in-depth view of ion
channels in brain tumors, see Ding et al. (2012).
ASICs are cation-nonspecific (Na+, K+, and sometimes Ca2+)
ion channels that are usually opened by low pHe and are
FIGURE 2 | Examples of pH-dependent physiology in solid tumors. (1)
Radiation efficacy. (2) Salt water flux via K+, Cl−, and H2O channels. (3)
Downstream expression patterns of tumorigenic genes. (4) Mislocalization
of cyclin D1 and disruption of the cell cycle. (5) Ca2+ permeation through
ion channels (ASIC, P2X, TRP) and subsequent downstream effects. (6)
Metabolic enzyme activity. (7) H+-coupled lactate efflux. (8) Vesicular fusion
and protease enzymatic activity. (9) Interaction with the extracellular matrix.
(10) Distribution of weak acids/bases.
transiently active. ASICs 1 and 2 have been shown to be expressed
in human glioma cells (Berdiev et al., 2003), with sensitivity to
psalmotoxin 1 in addition to amiloride (Bubien et al., 2004). The
Na+ current derived from glioma ASIC expression contributes to
their volume regulation (Ross et al., 2007) and migration (Vila-
Carriles et al., 2006; Kapoor et al., 2009). Interestingly, a hybrid
of ASIC and epithelial sodium channel (ENaC) subunits creates
a basally active conductance (Kapoor et al., 2011) that affects
glioma cell migration and cell cycle progression (Rooj et al.,
2012). This hybrid channel is recruited to the plasma membrane
in the face of acidic pHe as found in the tumor core (Kapoor et al.,
2011). Under acidotic conditions, the role of ASIC1a and ASIC2a
seems paradoxical: ASIC1a knockdown prevents Ca2+-mediated
injury (Weng et al., 2007), while ASIC2a knockdown aggravates it
(Liu et al., 2011).
TRPs are also cation-nonspecific channels, whose pH-
sensitivities play a role in the proton-heavy environments of taste
buds, pain receptors, and cancer cells. In brain tumor cells, the
expression of TRPC channels has been especially tied to Ca2+
influxmediating changes in cell morphology andmovement. This
includes cytokinesis (Bomben and Sontheimer, 2008, 2010), Ca2+
mobilization (Nakao et al., 2008; Chigurupati et al., 2010), and
cell migration (Chigurupati et al., 2010; Bomben et al., 2011).
Unlike TRPC channels, TRPV channel expression tends to neg-
atively affect glioma cells, leaving them vulnerable to capsaicin-
induced apoptosis (Amantini et al., 2007) and chemotherapeutic
cytotoxicity (Nabissi et al., 2013), as well as promoting differen-
tiation (Morelli et al., 2012). Interestingly, neural precursor cells
(NPCs) release endogenous TRPV agonists that prevent glioma
cells from attacking the juvenile brain (Stock et al., 2012), a
phenomenon that is lost with a loss of NPCs during aging.
P2XRs are ATP-gated cation channels, while P2YRs are
purinergic-coupled GPCRs. Together, they are most extensively
studied for their involvement in Ca2+ flux in glioma cell signal
transduction, tumor progression, and cell death. In general, these
receptors are proton-potentiated (Glitsch, 2011). For a compre-
hensive review of purinergic signaling in glioma cells, refer to
Barañska (2013); for the pH-sensitivities of these channels, refer
to Stoop et al. (1997), Gerevich et al. (2007).
K2P channels and pH-sensitive GPCRs have not been stud-
ied extensively in brain tumor tissue, though their roles in other
cancers have been elucidated (Sin et al., 2004; Innamaa et al.,
2013). The K2P members TASK-1 and TASK-3, pH-sensitive
background K+ channels, have functional expression in human
medulloblastoma cells (Ernest et al., 2010) and have been func-
tionally implicated in glioma cell survival (Meuth et al., 2008).
The pH-sensitive GPCRs OGR1 and G2A are also expressed in
human medulloblastoma cells and regulate intracellular Ca2+
signaling in response to extracellular pH (Huang et al., 2008).
VOLUME REGULATION AND CELL MOVEMENT
Gliomas are highly invasive, quickly seeding the brain with satel-
lite tumors. This is especially impressive in the crowded brain
space and requires a coordinated effort of cell shrinkage, pro-
cess extension, and path-clearing. Volume regulation is a vital
component of the first two functions and requires salt water
flux (cation + anion + H2O; Figure 2) (Sontheimer, 2008;
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Watkins and Sontheimer, 2011). Two of the most well-studied
ion channels in glioma cell migration, BK for K+ ions and ClC-3
for Cl− ions, are pH-sensitive. More specifically, low pHe blocks
both channels, while low pHi stimulates BK channels, all within
a physiological range of pH 6–8 (Avdonin et al., 2003; Brelidze
and Magleby, 2004; Matsuda et al., 2008, 2010). Additionally, as
described beforehand, proton flux through glioma cells is directly
tied to osmotically-active Na+ and lactate, which both then con-
tribute to volume regulation (Jakubovicz and Klip, 1989; Staub
et al., 1990). Thus, protons can both directly and indirectly con-
tribute to glioma cell volume regulation, which then affects cell
movement.
Proton concentrations also both alter shape and orient
tumor cells. This has been most thoroughly studied regard-
ing NHE in melanoma cells, though gliomas similarly possess
increased NHE1 activity versus their non-transformed counter-
parts (McLean et al., 2000) with specific microdomain localiza-
tion (Willoughby et al., 2005). In melanoma cells, NHE1 creates
a local pH gradient that dominates the bulk solution pH and
orients the cells via pH-dependence of integrin α2β1 stickiness
(Stock et al., 2005; Stuwe et al., 2007; Martin et al., 2011).
Intracellularly, NHE1 also organizes the cytoskeleton of cells. For
instance, the Rho GTPase Cdc42 recruits NHE1 to the leading
edge of the cell, increasing leading edge pHi and activating Cdc42
via a guanine nucleotide exchange factor, thus, maintaining polar-
ized cytoskeletal growth (Frantz et al., 2007). Similarly, cortactin
phosphorylation recruits NHE1 to the invadopodium, where it
alkalinizes pHi and induces actin polymerization via cortactin
release of cofilin (Magalhaes et al., 2011), thus playing an inte-
gral role in invadopodium protrusion/retraction cycling. NHE1 is
further activated at the invadopodium by p90 ribosomal S6 kinase
under hypoxic conditions (Lucien et al., 2011).
TISSUE DESTRUCTION
Brain tumors also cause direct destruction of surrounding tis-
sue, including both neuronal death via glutamate excitotoxicity
(Ye and Sontheimer, 1999) and degradation of the extracellu-
lar matrix via metalloproteinases (MMPs) and other proteases
(Nakada et al., 2003). It is well-established that protease activ-
ity is pH-dependent (Fasciglione et al., 2000; Gioia et al., 2010).
Additionally, however, acidic pHe both induces MMP-9 expres-
sion (Kato et al., 2005) and enhances the rupture of protease-
containing vesicles (Taraboletti et al., 2006), hinting at acidosis
driving tumor invasion (Figure 2). RNAi inhibition of MMP-
9 and the protease cathepsin B dramatically reduced tumor
pathogenicity of gliomas both in vitro and in vivo (Lakka et al.,
2004).
Here again NHE1 plays a role. While in the intracellular com-
partment NHE1-dependent alkalinization coordinates tumor cell
invasion, in the extracellular compartment the consequent acid-
ification is essential for proteolysis of the extracellular matrix
(Busco et al., 2010). Interestingly, preventing ion translocation
through NHE1 alone was sufficient to alter the gene profile of
mammalian fibroblasts, including a decrease in MMP-9 expres-
sion (Putney and Barber, 2004).
Finally, the excitotoxic process is itself pH-dependent.
Excitatory amino acid transporter 2 (EAAT-2), expressed in
low-grade brain tumors (De Groot et al., 2005), cotrans-
ports protons along with glutamate and thus is pH-dependent
(Vandenberg et al., 1998). The alanine-cysteine-serine transporter
2 (ASCT2) also transports glutamate, and it has shown pH-
dependence in C6 glioma cells (Doliñska et al., 2003). Lastly, the
NMDA glutamate receptors in part responsible for neuronal exci-
totoxicity are inhibited by protons (Traynelis and Cull-Candy,
1990).
METABOLIC ACTIVITY
Gliomas, like most other cancers, demonstrate the Warburg
effect—a preference for glycolysis over oxidative phosphorylation
even in the presence of ample oxygen. This leads to increased
intracellular lactate buildup, which is cleared via the cotransport
of lactate and protons via MCTs (Figure 2). Thus, inhibition of
these cotransporters via drug or decreased pHe both decreases
pHi (Volk et al., 1997) and increases intracellular lactate lev-
els (Lomneth et al., 1990). As many glycolytic enzymes prefer
the slightly alkaline pHi of glioma cells—lactate dehydrogenase
displays maximal activity at pHi 7.5 while phosphofructokinase
1 works best between pHi 7.0 and 7.5 (Webb et al., 2011)—
there is an intimate coupling of glioma pH regulation and cell
metabolism. This connection likely governs the expression pat-
terns of pH-associated proteins across the glioma mass (Grillon
et al., 2011).
CELL SIGNALING
It is often difficult to separate the consequences of the various
conditions found within a tumor; levels of CO2, O2, lactate, waste
products, and pH distribute through the tumor heterogeneously,
and all can influence the cellular phenotype. A few studies have
specifically implicated acidosis in an alteration of glioma cell state.
For instance, a pHe of 6.6 upregulated VEGF mRNA and protein
expression in human GBM cells via the ERK1/2 MAPK signal-
ing cascade (Xu et al., 2002). Acidosis (pHe 6.5) also maintained
the stemness of glioma cells as determined both by stem cell
markers and cellular phenotype via hypoxia inducible factor 2α
(HIF2α) signaling (Hjelmeland et al., 2011). Acyl-CoA synthetase
5 (ACSL5) promotes glioma cell survival under low pHe condi-
tions through midkine (MDK) signaling (Mashima et al., 2009).
CA IX, known to be upregulated during times of hypoxia via the
HIF1α pathway (Wykoff et al., 2000), is also upregulated by low
pHe independent of hypoxia in GBM cells via the same pathway
(Ihnatko et al., 2006). Finally, very low pHe (6.0) arrested glioma
cells in the G1 phase of the cell cycle as a downstream result of
cyclin D1 mislocalization (Figure 2) and degradation in T98G
human glioma cells (Schnier et al., 2008).
THERAPY SENSITIVITY
A heterogeneous pH environment creates a moving target for
both radiation and chemotherapeutics. Weak base and weak
acid drugs find themselves confined to either the intracellular or
extracellular spaces (Figure 2), depending on pHe and pHi, in a
phenomenon known as “ion trapping” (Raghunand and Gillies,
2000). This can result in heterogeneous drug potency across the
tumor mass, and has led to efforts to either acidify or alkalinize
the tumor in an attempt to localize chemotherapeutics to either
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the intra- or extracellular compartment. In gliomas, mild acidosis
inhibits cell growth while protecting cells from chemotherapeutic
cytotoxicity (Reichert et al., 2002). Attempts have been made
to artificially alkalinize solid tumors with NaHCO3-induced
metabolic alkalosis to enhance weak base uptake (Raghunand
et al., 2001), though none of these studies have yet been per-
formed in brain tumors. pH also can affect the radiosensitivity of
cells (Bosi et al., 1991), though its effect on glioma cells appears
inconsistent (Reichert et al., 2002).
With highly buffered ions such as Ca2+ and protons, nanomo-
lar changes in the free ion concentration equate to severalfold
shifts and drastic changes in central nervous system (CNS) signal-
ing. It is this context that separates brain tumors from other solid
tumors—the pathophysiological implications of large pH hetero-
geneity in a susceptible environment are greater than in many
other, more robust organs. This also leads to great opportunity—
brain tumors lean heavily on pH regulation to continue their
growth and invasion, and thus disruption of proton transport
could devastate tumor function while leaving normal tissue rel-
atively unharmed.
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